EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Association between fifteen peripheral blood inflammatory markers and cancer prevalence: a cross-sectional study based on NHANES and a Chinese hospital cohort

Can Liu, Haitian Zhang, Jinsong Zhang, Yan Li, Biyi Wang, Jun Ma, Hongjin Shi, Bing Hai

Frontiers in Oncology · 12.11.2026 · 16

DOI: 10.3389/fonc.2026.1948071 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Frontiers in Oncology, online erschienen am 12.11.2026. Verfasst von Can Liu und 7 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic low-grade inflammation has been associated with cancer, but comparative data on routine inflammatory markers in individuals with a history of cancer (prevalent cancer) remain limited. We examined associations between 15 peripheral blood inflammatory markers and cancer prevalence in a US general population and a Chinese hospital cohort.

Methods

We analyzed the NHANES cohort and a hospital cohort from the Second Affiliated Hospital of Kunming Medical University. Fifteen markers were calculated from routine blood tests. Weighted multivariable logistic regression, restricted cubic splines, and subgroup analysis were used.

Results

In NHANES, MLR, NMLR, SIRI, NLR, CAR, CLR, HALP, IBI, and NPAR were positively associated with cancer prevalence in continuous analysis, whereas PAR was inversely associated; LMR showed a significant nonlinear inverse association (P overall < 0.0001, P nonlinear = 0.0189) only in quartile analysis (Q4 OR = 0.64, 95% CI: 0.51–0.80). In the hospital cohort, MLR, NMLR, SIRI, SII, NLR, PLR, CAR, CLR, PIV, IBI, NPAR, and PAR were positively associated with cancer prevalence, while LMR and CALLY were inversely associated. In the overall NHANES cohort, MLR, NMLR, SIRI, SII, NLR, PIV, IBI, and NPAR were associated with higher all-cause mortality (2,257 deaths among 17,644 participants), whereas LMR and CALLY were associated with lower mortality.

Conclusion

Peripheral blood inflammatory markers are cross-sectionally associated with cancer prevalence and with mortality among cancer survivors. These findings do not establish incident cancer risk, causality, screening performance, or clinically actionable risk thresholds. Prospective studies are needed.

Zitieren

APA

Liu, C., Zhang, H., Zhang, J., Li, Y., Wang, B., Ma, J., Shi, H., & Hai, B. (2026). Association between fifteen peripheral blood inflammatory markers and cancer prevalence: a cross-sectional study based on NHANES and a Chinese hospital cohort. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1948071

Vancouver

Liu C, Zhang H, Zhang J, Li Y, Wang B, Ma J, et al. Association between fifteen peripheral blood inflammatory markers and cancer prevalence: a cross-sectional study based on NHANES and a Chinese hospital cohort. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1948071

BibTeX
@article{Liu2026,
  author = {Liu, Can and Zhang, Haitian and Zhang, Jinsong and Li, Yan and Wang, Biyi and Ma, Jun and Shi, Hongjin and Hai, Bing},
  title = {Association between fifteen peripheral blood inflammatory markers and cancer prevalence: a cross-sectional study based on NHANES and a Chinese hospital cohort},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1948071}
}
Kostenlos starten →